FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564758975> ?p ?o ?g. }

• W2564758975 abstract "Background. Purpose of the work – to investigate the possible relationship of the cardiovascular risk main factors with certain polymorphism of aldosterone synthase gene (CYP11B2).Materials and methods. Аt the Cardiology Department of PL Shupyk NMAPE general clinical examination of 378 patients was held. Patients were divided into four groups: 100 patients with postinfarction cardiosclerosis, 78 patients with CAD without myocardial infarction in history, 100 high cardiovascular risk patients (with diabetes, hypertension or dyslipidemia) and 100 healthy patients (absence of cardiovascular disease was confirmed by medical history, ECG, blood pressure measurement and stress-ECG).Genetic testing was performed by polymerase chain reaction in real time at the Institute of Physiology named after O. O. Bogomolets.Exclusion criteria were hemodynamically significant valvular heart disease, chronic obstructive pulmonary disease, permanent or temporary heart pacing, acute heart failure and implanted cardioverter-defibrillator, permanent form of atrial fibrillation.Statistical analysis of the results was performed using Microsoft Excel, the statistical program SPSS (version 13US).Results. When analyzing the average levels of low density lipoprotein (LDL) cholesterol statistically significant difference between the group of patients with postinfarction cardiosclerosis and the group of high-risk patients (2.93±1.2 mmol/L vs 3.4±1.2 mmol/L, p=0.0075) was demonstrated, indicating a better cholesterol control in the group of patients with postinfarction cardiosclerosis, despite the fact that the average cholesterol level did not reach the target.The highest average levels of triglycerides (TG) were observed in patients with postinfarction cardiosclerosis – 1.56±0.725 mmol/L, intermediate – in patients with stable coronary artery disease – 1.39±0.795 mmol/L, and the lowest – in high cardiovascular risk patients – 1.04±0.565 mmol/L, with significant differences between all groups. The level of total cholesterol in patients with postinfarction cardiosclerosis was significantly higher in the subgroup of patients with homozygous recessive variant CC (5.8±1.08 mmol/L), compared with heterozygotes TC (4.87±1.3 mmol/L, p=0.024 ) and had no statistical significance when compared with the dominant TT homozygotes (5.06±1.45 mmol). Higher levels of total cholesterol (5.76±1.5 mmol/L) in TT homozygotes compared with TC (4.92±1.27 mmol/L, p=0.027) and CC (4.74±1.23 mmol/L, p=0.022) were found. In the group of patients with postinfarction cardiosclerosis, LDL cholesterol in the subgroup homozygous recessive variant CC was higher (3.43±0.87 mmol/L) (not significant) compared with a TT variant (3.02±1.3 mmol/L) and compared with heterozygotes TC (2.78±1.2 mmol/L, p=0.08). The level of TG in patients with stable coronary heart disease was the lowest in dominant homozygotes TT (1.13±0.56 mmol/L) compared with CT heterozygotes (1.54±0.97 mmol/L, p=0.08) and CC homozygotes (1.36±0.58 mmol/L, p=0.2).Conclusions.1. Group of high cardiovascular risk patients requires special attention in the prevention of cardiovascular diseases, because this group showed the worst control of cardiovascular risk factors (level of total cholesterol, LDL cholesterol, glucose, SBP) in the absence of appropriate treatment.2. Ingroup of patients with stable coronary artery disease and postinfarction cardiosclerosis the link CC variant gene polymorphism of aldosterone synthase CYP11B2-344C/T with higher levels of total cholesterol, LDL cholesterol was established, which increases the cardio-vascular risk in this group.3. CC polymorphism of aldosterone synthase gene CYP11B2-344C/T was associated with higher levels of SBP in patients with stable coronary artery disease and postinfarction cardiosclerosis, which increases the cardiovascular risk such as the development of hypertension." @default.
• W2564758975 created "2017-01-06" @default.
• W2564758975 creator A5047175747 @default.
• W2564758975 creator A5055253452 @default.
• W2564758975 creator A5061981565 @default.
• W2564758975 date "2016-12-08" @default.
• W2564758975 modified "2023-10-05" @default.
• W2564758975 title "Gene polymorphism of aldosterone synthetase (CYP11B2) variants and main cardiovascular risk factors" @default.
• W2564758975 cites W1967020579 @default.
• W2564758975 cites W1984312453 @default.
• W2564758975 cites W1984476856 @default.
• W2564758975 cites W1985770217 @default.
• W2564758975 cites W1986725360 @default.
• W2564758975 cites W1990307219 @default.
• W2564758975 cites W2002921189 @default.
• W2564758975 cites W2025123345 @default.
• W2564758975 cites W2036876430 @default.
• W2564758975 cites W2060204451 @default.
• W2564758975 cites W2064046486 @default.
• W2564758975 cites W2093493729 @default.
• W2564758975 cites W2099112907 @default.
• W2564758975 cites W2108548563 @default.
• W2564758975 cites W2135207001 @default.
• W2564758975 cites W2137166582 @default.
• W2564758975 cites W2144178752 @default.
• W2564758975 cites W2144660445 @default.
• W2564758975 cites W2149081700 @default.
• W2564758975 cites W2154375739 @default.
• W2564758975 cites W2163991033 @default.
• W2564758975 cites W2164265846 @default.
• W2564758975 cites W2168800815 @default.
• W2564758975 cites W2169398944 @default.
• W2564758975 cites W25157514 @default.
• W2564758975 cites W2601206095 @default.
• W2564758975 cites W2396618720 @default.
• W2564758975 doi "https://doi.org/10.14739/2310-1210.2016.6.85482" @default.
• W2564758975 hasPublicationYear "2016" @default.
• W2564758975 type Work @default.
• W2564758975 sameAs 2564758975 @default.
• W2564758975 citedByCount "0" @default.
• W2564758975 crossrefType "journal-article" @default.
• W2564758975 hasAuthorship W2564758975A5047175747 @default.
• W2564758975 hasAuthorship W2564758975A5055253452 @default.
• W2564758975 hasAuthorship W2564758975A5061981565 @default.
• W2564758975 hasBestOaLocation W25647589751 @default.
• W2564758975 hasConcept C104317684 @default.
• W2564758975 hasConcept C126322002 @default.
• W2564758975 hasConcept C135763542 @default.
• W2564758975 hasConcept C149737253 @default.
• W2564758975 hasConcept C198710026 @default.
• W2564758975 hasConcept C2778525890 @default.
• W2564758975 hasConcept C2780249997 @default.
• W2564758975 hasConcept C54355233 @default.
• W2564758975 hasConcept C71924100 @default.
• W2564758975 hasConcept C84393581 @default.
• W2564758975 hasConcept C86803240 @default.
• W2564758975 hasConceptScore W2564758975C104317684 @default.
• W2564758975 hasConceptScore W2564758975C126322002 @default.
• W2564758975 hasConceptScore W2564758975C135763542 @default.
• W2564758975 hasConceptScore W2564758975C149737253 @default.
• W2564758975 hasConceptScore W2564758975C198710026 @default.
• W2564758975 hasConceptScore W2564758975C2778525890 @default.
• W2564758975 hasConceptScore W2564758975C2780249997 @default.
• W2564758975 hasConceptScore W2564758975C54355233 @default.
• W2564758975 hasConceptScore W2564758975C71924100 @default.
• W2564758975 hasConceptScore W2564758975C84393581 @default.
• W2564758975 hasConceptScore W2564758975C86803240 @default.
• W2564758975 hasLocation W25647589751 @default.
• W2564758975 hasLocation W25647589752 @default.
• W2564758975 hasOpenAccess W2564758975 @default.
• W2564758975 hasPrimaryLocation W25647589751 @default.
• W2564758975 hasRelatedWork W1126044527 @default.
• W2564758975 hasRelatedWork W1980559609 @default.
• W2564758975 hasRelatedWork W2152585030 @default.
• W2564758975 hasRelatedWork W2153642659 @default.
• W2564758975 hasRelatedWork W2172016508 @default.
• W2564758975 hasRelatedWork W2387467656 @default.
• W2564758975 hasRelatedWork W3015296784 @default.
• W2564758975 hasRelatedWork W4233585818 @default.
• W2564758975 hasRelatedWork W4286924426 @default.
• W2564758975 hasRelatedWork W4387029251 @default.
• W2564758975 isParatext "false" @default.
• W2564758975 isRetracted "false" @default.
• W2564758975 magId "2564758975" @default.
• W2564758975 workType "article" @default.